916MO Safety and efficacy of MEDI0457 plus durvalumab in patients (pts) with human papillomavirus-associated recurrent/metastatic head and neck squamous cell carcinoma (HPV+ R/M HNSCC)
| Autor: | Aggarwal, C., Saba, N.F., Algazi, A.P., Sukari, A., Seiwert, T., Haigentz, M., Porosnicu, M., Bonomi, M., Boyer, J., Durham, N., Kumar, R., Laubscher, K., Gong, M., Ceaicovscaia, N., Gascó Hernández, A. |
|---|---|
| Zdroj: | In Annals of Oncology September 2020 31 Supplement 4:S661-S662 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|